Indication hub
Peripheral Artery Disease clinical trials — Miami
Amavita Research is the GCSA-certified Miami cardiovascular trial site: senior principal investigator and interventional cardiologist with a structural-heart (TAVR) research background, an in-house South Florida heart practice, and a dedicated cardiovascular ASC.
Peripheral artery disease work at Amavita Research uses the dedicated cardiovascular ASC for interventional procedures. The public homepage study in this indication is GREAT. Dr. Pedro Martinez-Clark is the principal investigator on that study.
Public studies
- PivotalEnrollingGREAT — Golazo® Peripheral Atherectomy System
Sponsor: Avantec Vascular
The GREAT Trial evaluates the Golazo® Peripheral Atherectomy System for safe and effective atherectomy in patients with peripheral artery disease. Phase: device IDE study.
Investigators
Why Amavita Research for peripheral artery disease
- Operating cardiovascular ASC at 9408 SW 87th Ave, Suite 303, Miami, FL 33176 for peripheral intervention.
- Operating legal address, clinical trial site and heart practice at 100 NW 170 St, Suite 305, North Miami Beach, FL 33169.
- In-house South Florida heart practice for PAD patient identification.
- IAOCR GCSA-certified (Feb 2025). ICH-GCP E6(R3).
New-sponsor first-touch
Julio G. Martinez-Clark
CEO, Amavita Research Services, LLC
New-sponsor first-touch, CDA, and NDA. Julio signs CDAs. Dr. Pedro Martinez-Clark is a principal investigator only. After a study is awarded, Nereisy Alonso, Sr CRC, COO owns study operations: monitors and start-up logistics.
Contact Julio about a protocolLocations
Where this work happens
- Operating North Miami Beach location at 100 NW 170 St, Suite 305. This is the legal address, clinical trial site and heart practice.
- Operating Kendall cardiovascular surgery center at 9408 SW 87th Ave, Suite 303, Miami, FL 33176.